Arcturus Therapeutics Holdings Inc.
ARCT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001768224
No open-market purchases or sales by Arcturus Therapeutics Holdings Inc. insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $167.9M in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2024
Institutional positions in Arcturus Therapeutics Holdings Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 171
- −5 vs. Q1 2024
- Shares held
- 26.3M
- −870.4K (−3.2%) vs. Q1 2024
- Total value
- $640.0M
- −$276.5M (−30.2%) vs. Q1 2024
- New holders
- 35
- 45 more added
- Sold out
- 40
- 65 more reduced
3 institutions that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARCT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 135 | $167.9M |
| Q1 2026 | 124 | $187.3M |
| Q4 2025 | 121 | $145.1M |
| Q3 2025 | 137 | $476.8M |
| Q2 2025 | 145 | $336.3M |
| Q1 2025 | 147 | $282.9M |
| Q4 2024 | 149 | $452.5M |
| Q3 2024 | 164 | $609.3M |
| Q2 2024 | 171 | $640.0M |
| Q1 2024 | 179 | $918.7M |
| Q4 2023 | 166 | $801.6M |
| Q3 2023 | 147 | $643.1M |
| Q2 2023 | 144 | $677.6M |
| Q1 2023 | 124 | $557.9M |
| Q4 2022 | 113 | $383.9M |
| Q3 2022 | 117 | $328.1M |
| Q2 2022 | 128 | $353.6M |
| Q1 2022 | 129 | $578.1M |
| Q4 2021 | 139 | $736.2M |
| Q3 2021 | 157 | $909.0M |
| Q2 2021 | 139 | $694.0M |
| Q1 2021 | 162 | $776.0M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Arcturus Therapeutics Holdings Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Torno Capital, LLC | 0 | $0 | 0.00% | −4,700−100.0% | Sold out |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0 | $0 | 0.00% | −4,328−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −3,810−100.0% | Sold out |
| New Vernon Capital Holdings II LLC | 0 | $0 | 0.00% | −3,464−100.0% | Sold out |
| New York State Teachers Retirement System | 0 | $0 | 0.00% | −2,075−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −1,394−100.0% | Sold out |
| Dynamic Wealth Strategies, LLC | 0 | $0 | 0.00% | −650−100.0% | Sold out |
| Benjamin F. Edwards & Company, Inc. | 0 | $0 | 0.00% | −105−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −92−100.0% | Sold out |
| Nelson, Van Denburg & Campbell Wealth Management Group, LLC | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Sofos Investments, Inc. | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Credit Suisse AG | – | – | – | – | Not filed |
| Ziegler Capital Management, LLC | – | – | – | – | Not filed |
| Shell Asset Management Co | – | – | – | – | Not filed |